Finally, we confirmed that the combination of adiponectin with thrombopoietic agents promotes the transport of c‐Mpl to the cell surface by enhancing the expression of Rab6A GEFs, which might be a clinical treatment for alleviating thrombocytopenia. This evidence concerns the gene ADIPOQ and Thrombocytopenia.